GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Avanos Medical Inc (FRA:8HH) » Definitions » Enterprise Value

Avanos Medical (FRA:8HH) Enterprise Value : €1,107.0 Mil (As of Sep. 21, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Avanos Medical Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Avanos Medical's Enterprise Value is €1,107.0 Mil. Avanos Medical's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was €26.0 Mil. Therefore, Avanos Medical's EV-to-EBIT ratio for today is 42.53.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Avanos Medical's Enterprise Value is €1,107.0 Mil. Avanos Medical's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was €67.9 Mil. Therefore, Avanos Medical's EV-to-EBITDA ratio for today is 16.31.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Avanos Medical's Enterprise Value is €1,107.0 Mil. Avanos Medical's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was €631.7 Mil. Therefore, Avanos Medical's EV-to-Revenue ratio for today is 1.75.


Avanos Medical Enterprise Value Historical Data

The historical data trend for Avanos Medical's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avanos Medical Enterprise Value Chart

Avanos Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,530.57 1,895.40 1,526.53 1,313.47 1,044.04

Avanos Medical Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,245.37 1,078.39 1,044.04 970.81 957.35

Competitive Comparison of Avanos Medical's Enterprise Value

For the Medical Devices subindustry, Avanos Medical's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avanos Medical's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Avanos Medical's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Avanos Medical's Enterprise Value falls into.



Avanos Medical Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Avanos Medical's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Avanos Medical's Enterprise Value for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avanos Medical  (FRA:8HH) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Avanos Medical's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1106.977/26.027
=42.53

Avanos Medical's current Enterprise Value is €1,107.0 Mil.
Avanos Medical's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €26.0 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Avanos Medical's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=1106.977/67.865
=16.31

Avanos Medical's current Enterprise Value is €1,107.0 Mil.
Avanos Medical's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €67.9 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Avanos Medical's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1106.977/631.745
=1.75

Avanos Medical's current Enterprise Value is €1,107.0 Mil.
Avanos Medical's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €631.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avanos Medical Enterprise Value Related Terms

Thank you for viewing the detailed overview of Avanos Medical's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Avanos Medical Business Description

Traded in Other Exchanges
Address
5405 Windward Parkway, Suite 100 South, Alpharetta, GA, USA, 30004
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. The firm operates in one segment, medical devices, which primarily sells products related to pain management, IV Therapy, and respiratory and digestive health. The company divides its Medical Devices segment into two franchises: Pain Management and Chronic Care. Pain Management provides non-opioid products for acute and interventional pain, including cold and compression therapy. Chronic Care aims at addressing digestive and respiratory issues with feeding tubes and catheters. Avanos generates most of its revenue from its Chronic Care franchise and in North America.

Avanos Medical Headlines

No Headlines